Table 1. Characteristics of patients with MDR-TB.
| Variables | Number (%) |
|---|---|
| Demographic Factors | |
| Sex | |
| Male | 214 (64.8) |
| Female | 116 (35.2) |
| Age | |
| ≤ 30 years | 99 (30.0) |
| 31–50 years | 162 (49.1) |
| > 50 years | 69 (20.9) |
| Mean ± SD (39.45±13.28), Minimum 18, Maximum 77 | |
| BMI | |
| < 18.5 | 85 (25.8) |
| ≥ 18.5 | 245 (74.2) |
| Mean ± SD (20.96±2.79), Minimum 10.70, Maximum 26.20 | |
| Geographical Accessibility | |
| Residence | |
| Rural | 83 (25.2) |
| Urban | 247 (74.8) |
| Disease Factors | |
| Type of patient | |
| New case | 35 (10.6) |
| Previously treated case | 295 (89.4) |
| Relapse | 154 (52.2) |
| Treatment after failure (Category I) | 70 (23.7) |
| Treatment after failure (Category II) | 67 (22.7) |
| Default | 4 (1.2) |
| Contact with MDR-TB patient | |
| Absent | 212 (64.2) |
| Present | 118 (35.8) |
| Diabetes mellitus | |
| Absent | 301 (91.2) |
| Present | 29 (8.8) |
| HIV coinfection | |
| Absent | 298 (90.3) |
| Present | 32 (9.7) |
| Lung cavitation | |
| Absent | 307 (93.0) |
| Present | 23 (7.0) |
| Unilateral | 16 (69.6) |
| Bilateral | 7 (30.4) |
| Smear grade | |
| Negative | 28 (8.5) |
| 1+ | 142 (43.0) |
| 2+ | 66 (20.0) |
| 3+ | 94 (28.5) |
| Drug-resistance pattern | |
| HR | 296 (89.7) |
| SHR | 18 (5.5) |
| SHRE | 16 (4.8) |
| Treatment duration (n = 269) | |
| 20 months | 230 (85.5) |
| 24 months | 39 (14.5) |
| Culture conversion time (n = 269) | |
| Short (< 152 Days) | 117 (43.5) |
| Long (≥ 152 Days) | 152 (56.5) |
| Median 152, IQR 147 (94–241), Minimum 90, Maximum 365 | |
| Treatment outcome (n = 330) | |
| Successful | 269 (81.5) |
| Cured | 210 (63.6) |
| Completed | 59 (17.9) |
| Poor | 61 (18.5) |
| Lost to follow-up | 9 (0.03) |
| Failed | 3 (0.01) |
| Died | 48 (14.5) |
| Not evaluated | 1 (0.00) |
Abbreviations: MDR-TB, multidrug-resistant tuberculosis; SD, standard deviation; BMI, body mass index; IQR, interquartile range; S, streptomycin; H, isoniazid; R, rifampin; E, ethambutol.